Ameliora Wealth Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Ameliora Wealth Management’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-750	Closed	-$316	–	268
2022 Q4	$316	Hold	750	–	–	﹤0.01%	227
2022 Q3	$1K	Buy	+750	New	+$1.01K	﹤0.01%	224

Ameliora Wealth Management's AYLA Position: Q1 2023 in Review

Ameliora Wealth Management sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2023, closing a stake of 750 shares — an estimated $316 sold.

Ameliora Wealth Management first reported a position in AYLA in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold AYLA as of Q1 2023.

Ameliora Wealth Management reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Ameliora Wealth Management sold 750 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $316.
Ameliora Wealth Management first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Ameliora Wealth Management's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q3 2022.
0 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Ameliora Wealth Management's 13F filing for Q1 2023, filed 17 Apr 2023.